A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
A phase 1/2 trial of Prednisone, Docetaxel, Darolutamide in prostate cancer, run by Jiangsu HengRui Medicine Co., Ltd., now recruiting.
Overview
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer is a phase 1/2 interventional study registered as NCT06568094 by Jiangsu HengRui Medicine Co., Ltd., with 100 participants planned, started 2024-09-25 and due to reach its primary completion in 2026-06. Interventions recorded: HRS-5041 tablets, Abiraterone Acetate tablets（II）, Prednisone Acetate tablets, Docetaxel Injection, HRS-1167 tablets. Conditions listed: Prostate Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
Shares Prednisone, Jiangsu Hengrui Pharmaceuticals, Prostate cancer.
- TrialA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Ver
Shares Prednisone, Jiangsu Hengrui Pharmaceuticals, Prostate cancer.
- TrialA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Shares Prednisone, Docetaxel, Prostate cancer.
- TrialARASENS
Shares Darolutamide, Docetaxel, Prostate cancer.
- TrialA Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer
Shares Darolutamide, Prostate cancer.
- TrialA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Shares Prednisone, Docetaxel, Prostate cancer.
- TrialA Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have Hi
Shares Darolutamide, Prostate cancer.
- TrialA Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Shares Darolutamide, Prostate cancer.